Israel Chemical (ICL) Reports In-Line Q3 EPS

Israel Chemical (NYSE: ICL) reported Q3 EPS of $0.09, in-line with the analyst estimate of $0.09. Revenue for the quarter came in at $1.38 billion versus the consensus estimate of $1.51 billion.

For earnings history and earnings-related data on Israel Chemical (ICL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c